The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections

Open Access

Review articles summarize the best available evidence on a topic relevant to the NTD community.

Mark R. Hickman ,

* E-mail: mark.r.hickman.civ@army.mil

Affiliation Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), Fort Detrick, Maryland, United States of America

https://orcid.org/0000-0001-8183-2076

⨯
David L. Saunders,

Affiliation U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, United States of America
⨯
Catherine A. Bigger,

Affiliation Logistics Management International Inc, Tysons Corner, Virginia, United States of America
⨯
Christopher D. Kane,

Affiliation National Cancer Institute, Frederick, Maryland, United States of America

https://orcid.org/0000-0002-0469-1668

⨯
Patrick L. Iversen

Affiliation Oregon State University, Corvallis, Oregon, United States of America

https://orcid.org/0000-0003-0106-9790

⨯

Reader Comments (0)

Ebola virus
Is the Subject Area "Ebola virus" applicable to this article?

Thanks for your feedback.
Antiviral therapy
Is the Subject Area "Antiviral therapy" applicable to this article?

Thanks for your feedback.
COVID 19
Is the Subject Area "COVID 19" applicable to this article?

Thanks for your feedback.
Respiratory infections
Is the Subject Area "Respiratory infections" applicable to this article?

Thanks for your feedback.
Ebola hemorrhagic fever
Is the Subject Area "Ebola hemorrhagic fever" applicable to this article?

Thanks for your feedback.
Aerosols
Is the Subject Area "Aerosols" applicable to this article?

Thanks for your feedback.
SARS CoV 2
Is the Subject Area "SARS CoV 2" applicable to this article?

Thanks for your feedback.
Filoviruses
Is the Subject Area "Filoviruses" applicable to this article?

Thanks for your feedback.